Retrospective modeling study evaluates COVID-19's effects on HIV incidence in MSM, suggesting crucial public health strategies.
Government-imposed physical distancing restrictions during the COVID-19 pandemic disrupted biobehavioral HIV prevention practices and access to healthcare services. This study aimed to use a mathematical model to evaluate the impact of COVID-19 on the HIV epidemic among men who have sex with men in Australia, using empirical data. A retrospective modeling study. We developed a mathematical model to estimate monthly HIV incidence between January 2020 and August 2022. We obtained aggregated monthly data for sexual partners, condom use, HIV testing, pre-exposure prophylaxis (PrEP) use, and migration. Three scenarios were simulated: 1) a COVID-19 scenario; 2) a no COVID-19 scenario where input parameters remained at pre-COVID-19 values; and 3) a no COVID-19 scenario with continued PrEP scale-up. In the absence of the COVID-19 pandemic, 1,263 (95% Percentile Interval (PI): 880-1,706) infections would have occurred between January 2020 and August 2022 compared to 915 (95% PI: 638-1,282) for the COVID-19 scenario (a 27.6% reduction). Reduced sexual partners was the leading factor contributing to the change in HIV infections and diagnoses (-24.9% and -10.6%, respectively). MSM aged ≥50 years had a larger reduction (31.0%) in new HIV infections than their younger counterparts (19.9%). A substantial reduction in new HIV infections and diagnoses in Australia occurred during the COVID-19 pandemic, largely due to decreased numbers of sexual partners. This reduction underscores the need for sustained public health strategies leveraging reduced transmission rates to continue progress towards eliminating HIV in Australia.
No takes yet. Share an insight, caveat, or question.
Weng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: